Evidence map›Paper›PMID 25715999›Full record

ArticlePflugers Archiv : European journal of physiology2015

The role of KCa3.1 channels in cardiac fibrosis induced by pressure overload in rats.

Li-Mei Zhao, Li-Ping Wang, Hui-Fang Wang, Xiao-Zhen Ma, Dang-Xia Zhou, Xiu-Ling Deng

Abstract read
PubMed Publisher
In one paragraph

Article in Pflugers Archiv : European journal of physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. The KCa3.1 KCells · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. CaBritish journal of pharmacology · 2020
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. KJournal of the American Heart Association · 2019
    Article
  12. Article
  13. Article
  14. Oxidative stress promotes myocardial fibrosis by upregulating KPflugers Archiv : European journal of physiology · 2017
    Article
  15. Protective role of ACE2-Ang-(1-7)-Mas in myocardial fibrosis by downregulating KPflugers Archiv : European journal of physiology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Li-Mei ZhaoDepartment of Physiology and Pathophysiology, School of Medicine, Xi'an Jiaotong University, 76 West Yanta Road, Xi'an, 710061, Shaanxi, China.
Li-Ping WangDepartment of Physiology and Pathophysiology, School of Medicine, Xi'an Jiaotong University, 76 West Yanta Road, Xi'an, 710061, Shaanxi, China.
Hui-Fang WangDepartment of Pathology, Xi'an Guangren Hospital, Affiliated to School of Medicine, Xi'an Jiaotong University, 76 West Yanta Road, Xi'an, 710004, Shaanxi, China.
Xiao-Zhen MaDepartment of Physiology and Pathophysiology, School of Medicine, Xi'an Jiaotong University, 76 West Yanta Road, Xi'an, 710061, Shaanxi, China.
Dang-Xia ZhouDepartment of Pathology, School of Medicine, Xi'an Jiaotong University, 76 West Yanta Road, Xi'an, 710061, Shaanxi, China.
Xiu-Ling DengDepartment of Physiology and Pathophysiology, School of Medicine, Xi'an Jiaotong University, 76 West Yanta Road, Xi'an, 710061, Shaanxi, China. dengxl@mail.xjtu.edu.cn.
Xi'an Jiaotong University · CNTED University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The intermediate-conductance Ca(2+)-activated K(+) (KCa3.1) channels play a pivotal role in the proliferation and collagen secretion of cardiac fibroblasts. However, their contribution in cardiac fibrosis remains unknown. This study was designed to investigate whether KCa3.1 channels mediate the development of cardiac fibrosis. Pressure-overloaded rats were induced by abdominal aortic constriction and treated without or with KCa3.1 blocker (TRAM-34) or angiotensin type 1 receptor blocker (losartan) for 2 weeks. Besides the increase of blood pressure, angiotensin (Ang) II level in the plasma and myocardium, left ventricle mass and hydroxyproline concentration, myocardial hypertrophy, as well as significant collagen deposition in the perivascular regions and interstitium of the myocardium were observed in pressure-overloaded rats. The expression of leukocyte differentiation antigens (CD45 and CD3), macrophage surface marker (F4/80), tumor necrosis factor alpha, and monocyte chemotactic protein-1 (MCP-1) also significantly increased. All these alterations were prevented by losartan and TRAM-34. TRAM-34 also reduced the increase of renin and angiotensinogen in the plasma and myocardium of pressure-overloaded rats. Ang II promoted the migration of monocytes through endothelial cells and the secretion of MCP-1 from human umbilical vein endothelial cells in vitro, which was inhibited by TRAM-34. In conclusion, the present study demonstrates that TRAM-34 alleviates cardiac fibrosis induced by pressure overload, which is related to its inhibitory action on KCa3.1 channels and Ang II level. Our findings indicate that the inhibition of KCa3.1 channels may represent a novel approach of preventing the progression of cardiac fibrosis, and also add to the already developing literature of promising targets for TRAM-34.

Indexed as

Angiotensin II Type 1 Receptor BlockersAngiotensinogenAnimalsAorta, AbdominalBlood PressureCardiomegalyCytokinesFibrosisHydroxyprolineLosartanMaleMyocardiumPotassium Channel BlockersPyrazolesRatsRats, Sprague-DawleyAngiotensin II Type 1 Receptor BlockersAngiotensinogenCytokinesHydroxyprolineKcnc1 protein, ratLosartanPotassium Channel BlockersPyrazolesReninShaw Potassium ChannelsTRAM 34Angiotensin IICardiac fibrosisIntermediate-conductance Ca2+-activated potassium channelsMigrationMonocyte

Identifiers

PMID25715999
OpenAlexW2147423181

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.